Circ-RPL15 was upregulated in CLL patients and correlated with poor OS and immunoglobulin heavy-chain variable region (IGHV) mutation used in the validation of CLL prognosis (Wu Z. et al., 2019). This evidence concerns the gene RPL15 and B-cell chronic lymphocytic leukemia.